308 related articles for article (PubMed ID: 15083379)
1. Aromatase inhibitors: new endocrine treatment of breast cancer.
Brueggemeier RW
Semin Reprod Med; 2004 Feb; 22(1):31-43. PubMed ID: 15083379
[TBL] [Abstract][Full Text] [Related]
2. Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectives.
Santen RJ
Breast Cancer Res Treat; 1986; 7 Suppl():S23-35. PubMed ID: 3527304
[TBL] [Abstract][Full Text] [Related]
3. Clinical use of aromatase inhibitors in the treatment of advanced breast cancer.
Trunet PF; Vreeland F; Royce C; Chaudri HA; Cooper J; Bhatnagar AS
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):241-5. PubMed ID: 9365196
[TBL] [Abstract][Full Text] [Related]
4. Aromatase inhibitors and breast cancer.
Brodie AM; Njar VC
Semin Oncol; 1996 Aug; 23(4 Suppl 9):10-20. PubMed ID: 8824460
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of aromatase as treatment of breast carcinoma in postmenopausal women.
Santen RJ; Boucher AE; Santner SJ; Henderson IC; Harvey H; Lipton A
J Lab Clin Med; 1987 Mar; 109(3):278-89. PubMed ID: 3546561
[TBL] [Abstract][Full Text] [Related]
6. Biochemistry and pharmacology of 7alpha-substituted androstenediones as aromatase inhibitors.
Brueggemeier RW; O'Reilly JM; Lovely CJ; Ward PJ; Quinn AL; Baker D; Darby MV; Gu XJ; Gilbert NE
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):247-54. PubMed ID: 9365197
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro pharmacological studies of aminoglutethimide as an aromatase inhibitor.
Santen RJ; Santner SJ; Tilsen-Mallett N; Rosen HR; Samojlik E; Veldhuis JD
Cancer Res; 1982 Aug; 42(8 Suppl):3353s-3359s. PubMed ID: 7083200
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor vorozole.
de Jong PC; van de Ven J; Nortier HW; Maitimu-Smeele I; Donker TH; Thijssen JH; Slee PH; Blankenstein RA
Cancer Res; 1997 Jun; 57(11):2109-11. PubMed ID: 9187104
[TBL] [Abstract][Full Text] [Related]
9. 6-Hydroximinoandrostenedione, a new specific inhibitor of estrogen biosynthesis and its effect on T47D human breast cancer cells.
Gervais M; Tan L
Anticancer Res; 1993; 13(2):383-8. PubMed ID: 8517651
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of aminoglutethimide: structure/activity relationships and receptor interactions.
Nicholls PJ; Daly MJ; Smith HJ
Breast Cancer Res Treat; 1986; 7 Suppl():S55-67. PubMed ID: 3755630
[TBL] [Abstract][Full Text] [Related]
11. Overview of recent development of aromatase inhibitors.
Brodie AM
Cancer Res; 1982 Aug; 42(8 Suppl):3312s-3314s. PubMed ID: 7083192
[TBL] [Abstract][Full Text] [Related]
12. Aminoglutethimide--a new endocrine therapy in breast cancer. A cancer research review.
Harris AL
Exp Cell Biol; 1985; 53(1):1-8. PubMed ID: 3881300
[TBL] [Abstract][Full Text] [Related]
13. Regulation of aromatase activity within the breast.
Miller WR; Mullen P; Sourdaine P; Watson C; Dixon JM; Telford J
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):193-202. PubMed ID: 9365190
[TBL] [Abstract][Full Text] [Related]
14. Plasma estrogen suppression with aromatase inhibitors evaluated by a novel, sensitive assay for estrone sulphate.
Lønning PE; Geisler J; Johannessen DC; Ekse D
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):255-60. PubMed ID: 9365198
[TBL] [Abstract][Full Text] [Related]
15. Aromatase, its inhibitors and their use in breast cancer treatment.
Brodie AM
Pharmacol Ther; 1993 Dec; 60(3):501-15. PubMed ID: 8073072
[TBL] [Abstract][Full Text] [Related]
16. A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase.
Covey DF; Hood WF
Cancer Res; 1982 Aug; 42(8 Suppl):3327s-3333s. PubMed ID: 7083195
[TBL] [Abstract][Full Text] [Related]
17. Aromatase inhibition by an enzyme-activated irreversible inhibitor in human carcinoma cell cultures.
Brueggemeier RW; Katlic NE
Cancer Res; 1990 Jun; 50(12):3652-6. PubMed ID: 2340513
[TBL] [Abstract][Full Text] [Related]
18. Estrogen synthesis in human breast tumor and its inhibition by testololactone and bromoandrostenedione.
Dao TL
Cancer Res; 1982 Aug; 42(8 Suppl):3338s-3341s. PubMed ID: 7083197
[TBL] [Abstract][Full Text] [Related]
19. Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitors.
Brodie AM; Santen RJ
Crit Rev Oncol Hematol; 1986; 5(4):361-96. PubMed ID: 3094971
[TBL] [Abstract][Full Text] [Related]
20. Oestrogen formation in breast: clinical and biological importance.
Dowsett M; Detre S; Rowlands M; Grimshaw R
J Endocrinol; 1996 Sep; 150 Suppl():S59-63. PubMed ID: 8943788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
